A highly selective telomerase inhibitor limiting human cancer cell proliferation

EMBO Journal

Volumn 20, Issue 24, 2001, Pages 6958-6968

  Damm, Klaus ^a,b   Hemmann, Ulrike ^c,d   Garin Chesa, Pilar ^b   Hauel, Norbert ^e   Kauffmann, Iris ^e   Priepke, Henning ^e   Niestroj, Claudia ^b   Daiber, Christine ^b   Enenkel, Barbara ^b   Guilliard, Bernd ^b   Lauritsch, Ines ^b   Müller, Elfriede ^b   Pascolo, Emanuelle ^b   Sauter, Gabriele ^b   Pantic, Milena ^f,g   Martens, Uwe M ^f   Wenz, Christian ^h   Lingner, Joachim ^h   Kraut, Norbert ^c   Rettig, Wolfgang J ⁱ   Schnapp, Andreas ^b   more..

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^b Oncology Research   (Germany)

^c Genomics   (Germany)

^d SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

^e Chemistry   (Germany)

^f UNIVERSITY OF FREIBURG   (Germany)

^g UNIVERSITY OF FREIBURG   (Germany)

^h SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

ⁱ BOEHRINGER INGELHEIM RCV GMBH AND CO KG   (Austria)

Author keywords

Cancer; Inhibitor; Microarray; Senescence; Telomerase

Indexed keywords

BIBR 1532; BIBR 1591; TELOMERASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER; CANCER CELL; CELL DIVISION; CELL PROLIFERATION; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; MITOSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SENESCENCE; TELOMERE; TUMOR XENOGRAFT;

CELL DIVISION; ENZYME INHIBITORS; GENE EXPRESSION PROFILING; HUMANS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TELOMERASE; TELOMERE; TUMOR CELLS, CULTURED;

ANIMALIA; EUKARYOTA;

EID: 4243937106     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/20.24.6958     Document Type: Article

References (44)

1. Telomere shortening and tumour formation by mouse cells lacking telomerase RNA
2. Extension of life-span by introduction of telomerase into normal human cells
3. Telomere elongation in immortal human cells without detectable telomerase activity
4. Wafl/Cipl/Sdil on cellular gene expression: Implications for carcinogenesis, senescence, and age-related diseases
5. Variability at the telomeres of the human X/Y pseudoautosomal region
6. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity
7. Stabilization of short telomeres and telomerase activity accompany immortalization of Epstein-Barr virus-transformed human B lymphocytes
8. A biomarker that identifies senescent human cells in culture and in ageing skin in vivo
9. Telomere maintenance by recombination in human cells
10. Diverse signaling pathways activated by growth factor receptors induce broadly overlapping, rather than independent, sets of genes
11. The RNA component of human telomerase
12. Short dysfunctional telomeres impair tumorigenesis in the INK4aΔ2/3 cancer-prone mouse
13. Creation of human tumour cells with defined genetic elements
14. Inhibition of telomerase limits the growth of human cancer cells
15. Telomere loss: Mitotic clock or genetic time bomb?
16. Telomeres shorten during ageing of human fibroblasts
17. Human telomerase contains evolutionarily conserved catalytic and structural subunits
18. Telomere reduction in human colorectal carcinoma and with ageing
19. The serial cultivation of human diploid cell strains
20. Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death
21. Specific association of human telomerase activity with immortal cells and cancer
22. Gene expression profile of aging and its retardation by caloric restriction
23. Gene-expression profile of the ageing brain in mice
24. Expression monitoring by hybridization to high-density oligonucleotide arrays
25. Mitotic misregulation and human ageing
26. Short telomeres on human chromosome 17p
27. Accumulation of short telomeres in human fibroblasts prior to replicative senescence
28. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumour cells and during immortalization
29. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats
30. Telomerase catalytic subunit homologs from fission yeast and human
31. Telomere length measurements using digital fluorescence microscopy
32. Longevity, stress response, and cancer in aging telomerase-deficient mice
33. Purification, assay, and properties of RNA polymerase I and class I-specific transcription factors in mouse
34. One-step affinity purification protocol for human telomerase
35. A survey of telomerase activity in human cancer
36. Microarray analysis of replicative senescence
37. Replicative senescence: Implications for in vivo ageing and tumour suppression
38. Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalised human cell lines
39. Inhibition of human telomerase by a G-quadruplex-interactive compound
40. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span
41. Human telomerase contains two cooperating telomerase RNA molecules
42. Telomere dysfunction impairs DNA repair and enhances sensitivity to ionising radiation
43. Telomere shortening and apoptosis in telomerase-inhibited human tumour cells